Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Robust variance estimation for the case-cohort design

W E Barlow1

  • 1Center for Health Studies, Group Health Cooperative, Seattle, Washington 98101-1448.

Biometrics
|December 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erratum to "Gene expression signatures for tailoring adjuvant chemotherapy of luminal breast cancer: stronger evidence, greater trust": [Annals of Oncology 32 (2021) 1077-1082].

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Gene expression signatures for tailoring adjuvant chemotherapy of luminal breast cancer: stronger evidence, greater trust.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with adjuvant doxorubicin and cyclophosphamide (SWOG S9313).

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer.

Breast cancer research and treatment·2016
Same author

Germline genetic variants in ABCB1, ABCC1 and ALDH1A1, and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancer.

The pharmacogenomics journal·2013
Same author

Effect of previous benign breast biopsy on the interpretive performance of subsequent screening mammography.

Journal of the National Cancer Institute·2010
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026
Same journal

Finite mixtures of linear quantile regressions with concomitant variables: a solution to endogeneity in longitudinal data modeling.

Biometrics·2026
Same journal

Discussion on "INTACT: a method for integration of longitudinal physical activity data from multiple sources" by Jingru Zhang, Erjia Cui, Hongzhe Li, and Haochang Shou.

Biometrics·2026
See all related articles

A new robust variance estimator simplifies analysis for rare outcomes in large studies. This method, using a jackknife approach, is efficient for complex sampling and accurately estimates variance for survival data.

Area of Science:

  • Biostatistics
  • Epidemiology
  • Survival Analysis

Background:

  • Large cohort studies with rare outcomes necessitate efficient data collection strategies.
  • Existing sampling schemes, like the case-cohort design, aim to improve efficiency but require careful variance estimation.
  • Accurate variance estimation is crucial for reliable statistical inference in complex study designs.

Purpose of the Study:

  • To propose a simple, robust variance estimator for analyzing failure time data from complex sampling mechanisms.
  • To demonstrate the equivalence of the proposed estimator to existing robust methods for the Cox model.
  • To provide a practical tool for evaluating interventions like mammography screening in large cohort studies.

Main Methods:

  • Development of a jackknife-based robust variance estimator.

Related Experiment Videos

  • Theoretical comparison with the Lin and Wei (1989) robust variance estimator for the Cox model.
  • Simulation studies to assess the performance and accuracy of the proposed estimator.

    • Main Results:

    • The proposed jackknife variance estimator is shown to be equivalent to established robust estimators for the Cox model.
    • Simulation results confirm excellent agreement between the proposed estimator and corrected asymptotic estimates.
    • The estimator demonstrates appropriate test size, indicating reliable statistical power.

    Conclusions:

    • The proposed robust variance estimator offers a simplified and effective approach for analyzing complex survival data, particularly in studies of rare outcomes.
    • This method facilitates more accurate statistical inference and is applicable to various epidemiological research settings.
    • The technique is validated through its application to mammography screening data for breast cancer mortality reduction.